Health Catalyst
HCAT

$7.73

0.77%

Market Cap: 456M

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,300

Information Technology Computer Programming, Data Processing, Etc.

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 10 analysts

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

5,390% more call options, than puts

Call options by funds: $18.9M | Put options by funds: $345K

30% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 23

4% more funds holding

Funds holding: 166 [Q4 2023] → 173 (+7) [Q1 2024]

2% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 58

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 2 (+0) [Q1 2024]

0.85% less ownership

Funds ownership: 86.41% [Q4 2023] → 85.56% (-0.85%) [Q1 2024]

18% less capital invested

Capital invested by funds: $460M [Q4 2023] → $377M (-$83.5M) [Q1 2024]

See Fund Rankings

Research analyst outlook

10 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$8

3%

upside

Avg. target

$12.40

60%

upside

High target

$16

107%

upside

10 analyst ratings

10 positive

100%

0 neutral

0%

0 negative

0%

Evercore ISI Group Elizabeth Anderson	3%upside $8	Outperform Maintained	9 Jul 2024
Piper Sandler Jessica Tassan	81%upside $14	Overweight Maintained	6 Jun 2024
Canaccord Genuity Richard Close	42%upside $11	Buy Maintained	21 May 2024
Wells Fargo Stan Berenshteyn	68%upside $13	Overweight Maintained	10 May 2024
Cantor Fitzgerald Sarah James	107%upside $16	Overweight Reiterated	10 Apr 2024

See Analyst Rankings

Financial journalist opinion

Health Catalyst Announces New Credit Facility for up to $225,000,000

SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P. The Financing consists of (i) an initial term loan facility in an aggregate principal amount of $125,000,000 (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of $100,000,000.

Health Catalyst Announces New Credit Facility for up to $225,000,000

3 Overlooked Telehealth Stocks Poised for a Comeback

Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.

3 Overlooked Telehealth Stocks Poised for a Comeback

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Zacks Investment Research

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care.

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:

Health Catalyst to Participate in Upcoming Investor Conferences

Zacks Investment Research

3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare

Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.

3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare

Zacks Investment Research

Why Health Catalyst (HCAT) Might be Well Poised for a Surge

Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why Health Catalyst (HCAT) Might be Well Poised for a Surge

Zacks Investment Research

Wall Street Analysts See a 75.19% Upside in Health Catalyst (HCAT): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 75.2% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts See a 75.19% Upside in Health Catalyst (HCAT): Can the Stock Really Move This High?

Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®

SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite® , a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern environment. Today's health systems face significant challenges in navigating a path to clinical, operational, and financial success.

Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®

See News Rankings